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Available online 7 November 2015Naturally occurring astaxantin (ASX) is one of the noticeable carotenoid and dietary supplement, which has
strong antioxidant and anti-inﬂammatory properties, and neuroprotective effects in the brain through crossing
the blood–brain barrier. Specially,we are interested in the role of ASX as a brain food. AlthoughASXhas been sug-
gested to have potential beneﬁt to the brain function, the underlying molecular mechanisms and eventsmediat-
ing such effect remain unknown. Here we examined molecular factors in the hippocampus of adult mouse fed
ASX diets (0.1% and 0.5% doses) using DNA microarray (Agilent 4 × 44 K whole mouse genome chip) analysis.
In this study, we described in detail our experimental workﬂow and protocol, and validated quality controls
with the housekeeping gene expression (Gapdh and Beta-actin) on the dye-swap based approach to advocate
our microarray data, which have been uploaded to Gene Expression Omnibus (accession number GSE62197)
as a gene resource for the scientiﬁc community. This data will also form an important basis for further detailed
experiments and bioinformatics analysis with an aim to unravel the potential molecular pathways or mecha-
nisms underlying the positive effects of ASX supplementation on the brain, in particular the hippocampus.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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ID 15-054).1. Direct link to deposited data
Deposited data can be found here:
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?targ=self&form=
html&view=brief&acc=GSE62197. This is an open access article under2. Experimental design, materials and methods
Astaxathin (ASX), a red natural pigment of the carotenoid family,
has been suggested to play diverse biological roles in human health
through its powerful antioxidant properties [1,2]. Recent studies have
found that ASX could also possess neuroprotective properties and
might be useful against neurological disorders and in preventing the de-
cline of cognitive functions [3,4]. Nowadays, there has been a growing
understanding that the inﬂuence of nutrient compound on health is
complex and requires nutrigenomic studies to tease out themechanism
at the molecular level [5]. Hence, we initiated to investigate ASX-
induced transcriptomic proﬁling on the adult hippocampus in a
mouse model using a high-throughput DNA microarray approach.
Eleven-weeks-old male C57/BL6J mice were obtained from SLC, Co.,
Ltd. (Shizuoka, Japan). The mice were housed individually in standard
cages with a 12-h light/dark cycle. After one-week of acclimatization
rearing with standard powdered chow (an MF diet, Oriental Yeast,
Tokyo, Japan) andwater ad libitum, all micewere fed ASX or its placebo
powder (AstaREAL powder 20F based on 2% content of astaxanthin from
Haematococcus pluvialis; Fuji Chemical Industry, Toyama, Japan) at ﬁnal
consistency of 0.1%, 0.5% and 0% (control, hereafter abbreviated as CON)
ASX dose for four-weeks (n = 6/group). All the experimentalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the University of Tsukuba Animal Experiment Committee guidelines
for the Care and Use of Laboratory Animals. The sampling was per-
formed a day after the last day of ASX supplementation period to
avoid acute inﬂuence. Following the dissection of the brain, hippocam-
pus (right) were carefully removed and immediately deep frozen in liq-
uid nitrogen and stored at−80 °C in a deep freezer. The hippocampi
were individually ground in liquid nitrogen to make very ﬁne powders,
and then their powders were stored in aliquots at−80 °C till used for
total RNA extraction (Fig. 1A).Fig. 1. The experimental design for high-throughput DNAmicroarray analysis following astaxan
the mouse hippocampi was rapidly dissected and individually ground to a very ﬁne powder in
right hippocampus using QIAGENRneasyMini Kit, and their qualitywas conﬁrmed both spectro
each control and treatment (0.1% and 0.5% ASX)was pooled in each group (n=4). (C) The desig
CON × 0.5% ASX). The differentially expressed gene list was generated according to ≧/≦1.5/0.
changed gene by RT-PCR, and detailed annotation of data sets and bioinformatics using Ingenu3. Workﬂow for optimal DNA microarray analysis through the
quality assessment of total RNA
To obtain best results on theDNAmicroarray chip, the critical assess-
ment of high-quality RNA is required. The following steps were sequen-
tially performed to conﬁrm total RNA quantity and quality. Total RNA
was extracted from the powdered samples using the QIAGEN RNeasy
Mini Kit (QIAGEN, Germantown, MD, USA) according to an optimized
protocol [6–8]. Concentration and quality of total RNA were assessed a
spectrometric method with NanoPhotometer (IMPLEN, München,thin (ASX) supplementation. (A) ASX supplementationwas performed for four-weeks, and
liquid nitrogen using pre-chilled mortar and pestle. (B) Total RNA was extracted from the
metricmethod and formaldehyde-agarose gel electrophoresis. After this step, total RNA for
n of DNAmicroarray chipwas followed as per the dye-swap labeling (CON× 0.1% ASX and
75-fold compared to CON. (D) As next step after the microarray, further conﬁrmation of
ity Pathway Analysis (IPA) will be performed (manuscript to be published elsewhere).
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trophoresis (Fig. 1B). In this experiment, we assessed a good quality of
total RNA in all samples as shown by a value of spectrophotometric ab-
sorbance (via A260/280 and A260/230 ratio) greater then 1.8, respectively.
In addition, integrity of RNA that comprised the 28S and 18S ribosomal
RNA is evaluated by formaldehyde-agarose gel electrophoresis stained
with ethidium bromide as seen clearly on the gel images in Fig. 1B
(right-hand side image). For DNA microarray experiment, an equal
amount of total RNA (1000 ng) from four randomly chosen the pow-
dered samples was pooled. A mouse whole genome 4 × 44 K DNA mi-
croarray chip (Agilent Technologies, CA, USA; G4122F) was used for
global gene expression into the hippocampus, where the two-color
(Cy3 and Cy5 labels) in conjunction with dye-swap method [9–11]
was used (Fig. 1C). The gene expression data from this study on ASX
supplementation effects in the adult mouse hippocampus were
deposited in the Gene Expression Omnibus (GEO) database under the
accession number GSE62197, and will be used for further analysis and
study (Fig. 1D).
4. Conﬁrmation of housekeeping gene expression between RT-PCR
analysis and the obtained DNA microarray data
Here we performed the quality control procedure based on the
expression of two housekeeping genes (Gapdh and Beta-actin) by
semi-quantitative reverse transcription-PCR (RT-PCR) for all samples
(n = 4/group) used in the DNA microarray analysis. For this, cDNA
was synthesized from independent samples using AfﬁnityScript QPCR
cDNA Synthesis Kit (Agilent Technologies, La Jolla, CA, USA) accordingFig. 2. Expression of housekeeping genes, glyceraldehyde 3-phosphate dehydrogenase (Gapdh)
Gapdh and Beta-actinmRNA as a positive control was conﬁrmed by RT-PCR. The data from RT-P
groups (One-wayANOVA, n=4eachgroup). (A)Graphical presentation of the band intensities
the Beta-actin gene, the signal intensity in Cy3 and Cy5 labeling for all 10 probes with th
supplementation.to the manufacturer's protocol. The reaction mixture for RT-PCR was
prepared the EmeraldAmp PCR Master Mix (TaKaRa Shuzo, Shiga,
Japan) and then performed on Thermal-cycling (C1000™ Thermal
Cycler; Bio-Rad Laboratories, California, USA). We validated that both
the housekeeping genes were expressed at almost no differences
among the groups (P N 0.05) (Fig. 2A); the PCR ampliﬁed bands that
were visualized and quantiﬁed using the Image Quant LAS 4000 mini
(GE Healthcare, Tokyo, Japan) are shown in Fig. 2B. Furthermore, to
achieve reliability of gene expression under dye-swap on the DNA mi-
croarray approach, we conﬁrmed the expression of Beta-actin genes
for all 10 probes on the level of signal intensity and fold change. The
control (CON) and treated samples (0.1% and 0.5% ASX) were labeled
with Cy3 and Cy5, or with reversed Cy5 and Cy3, respectively. This re-
sult showed that the ﬂuorescent signal differences did not alter due to
our dye-swap approach, and the fold change on Beta-actin probes ap-
peared less than 1.5-fold (Fig. 2C), indicating that the expression of
housekeeping gene for positive control is stable hybridization between
reversed samples in the two-color DNA microarray approach.
5. Hybridization, normalization, and scatter plot distribution of
intensity values
It is well known that an accurate outcome of differentially expressed
genes from a microarray data requires the critical normalization of the
hybridization intensity before the differentially expressed genes
(among treatments) can be analyzed. In this study, we used the ﬁltering
with replication based on the value of log2 ratio that can determine a
systematic dependence on intensity spot in the two-color and dye-and Beta-actin, using RT-PCR and DNAmicroarray experiments. (A) Relative abundance of
CR are presented as the means± SEM, and there are no signiﬁcant differences among the
and (B) the gel image showing theRT-PCRproduct bands of all samples. (C) As an example,
e dye-swap DNA microarray are presented in the hippocampus at 0.1% and 0.5% ASX
Fig. 3. Intensity scatter plot of the two-color DNA microarray chip. All spots on the graph are calculated by the logarithms (log2) value of the Cy5/Cy3 ratio for a single gene probe.
(A, B) Gray spots, which represent all genes, in upper two graphs show the raw data from 0.1% and 0.5% ASX supplementation compared to CON. (C-F) Four graphs in the center indicate
thedye-swap analysis using chip 1 and chip 2. The cut-off for chip 1 and chip 2 is applied by anup- and down-regulated fold ratio of greater than or equal to 1.5 (indicated by red color) and
less than or equal to 0.75 (indicated by green color). Non-changes in expression genes are indicated by the vertical and horizontal spaces between the both colors on around the zero line.
For the dye-swap to take place (selection), the genes showing an up-regulated fold-change in chip 1 (red) need to show a corresponding down-regulated value in chip 2 (green) and vice
versa for the down-regulations (red). (G, H) The lower two graphs ﬁnally show the dye-swap scatter plots whichmanifest reliable/conﬁdent gene expression on the basis of integration
with chip 1 and 2 data analyses. The common regulated genes are shown; up-regulation for the pin color, down-regulation for the blue color.
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Fig. 4. Validation of a differently expressed gene, growth hormone (Gh) obtained from the DNA microarray experiment by RT-PCR. (A) Probe signal intensity of Gh gene by 0.1% and 0.5%
ASX is presented graphically on the both labels (Cy3 and Cy5). (B) RT-PCR result is conﬁrmed for relative abundance of GhmRNA, from the pooled sample cDNAs similar to that for the
microarray analysis. (C) RT-PCR result is conﬁrmed for relative abundance of GhmRNA for each individual sample cDNA. The data in (C) are presented as themeans± SEM, and there are
no signiﬁcant differences among the groups (One-way ANOVA, n= 4 each group).
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genes using the cut-off values (≧/≦1.5/0.75-fold versus CON)weremea-
sured by CONwith Cy5 dye and ASXwith Cy3 dye in chip 1, followed by
a swap of the dye labeling in the chip 2. Post-dye-swap and applied nor-
malization, the number of overall genes is gradually reduced from the
raw datasets (0.1% ASX; 44,480 genes, 0.5% ASX; 43,379 genes) to a
high conﬁdence of differentially expressed gene list (Fig. 3). As can be
seen in the representative scatter plots in Fig. 3, the pattern of distribu-
tion is similar between 0.1% and 0.5% ASX supplementation. Further-
more, the step of hybridization and washes with 60-mer probes was
carried out based on the process in the Agilent manufacturer's guide,
and the Agilent scanner (G2505C) was used to detect the signals on
the hybridized microarrays slide. Subsequently, the data for differential
expression of genes was generated by Agilent Feature Extraction soft-
ware (version 11.0.1.1, Agilent Technologies). As microarrays have
been known to show several systematic errors including labeling bias,
irregular feature morphologies, mismatched sample concentration and
cross hybridization, in the Agilent system these issues have been ad-
dressed by the development of the Feature Extraction algorithms [13].6. Validation of DNAmicroarray data by re-conﬁrmed RT-PCR result
To verify differentially expressed genes, as an example, we select-
ed one gene, namely growth hormone (Gh) gene that is highly up-
regulated in both 0.1% (10.29-fold) and 0.5% ASX supplementations
(4.29-fold) and conﬁrmed the validation for the expression between
the employed two-color microarray approach (Fig. 4A) and RT-PCR
experiment using the pooled samples and individual samples
(Fig. 4B and 4C). Similar tendency of its expression levels was ob-
served between the two experimental methods. To note, in the RT-
PCR result using individual samples (n = 4/group), there was no
signiﬁcant difference among three groups from One-way ANOVA
(P N 0.05), because it may be inﬂuenced by small number of samples
and slight variation in each group (Fig. 4C). Nevertheless, a clear
trend in RT-PCR is shown to be similar to the Cy3 and Cy5 values of
the microarray method, which is mentioned a good relevance for
positive control gene before [8]. This result demonstrates that a val-
idation procedure using a discrete tool needs to recognize the quality
of gene expression obtained in the microarray experiment. Thus, we
sought to present and discuss the deposited microarray data set as a
highly reliable dataset to understand the effect of ASX supplementa-
tion on the hippocampus in our mouse model.7. Discussion
Nutritional/dietary compoundsmay play an important role for brain
structure and its function, and these effects would be mediated by
changes in the genes [14]. DNA microarray analysis is a powerful ap-
proach to identify genome-wide gene expression in response to inter-
vention of nutrients on the central neuronal system referred to as
nutrigenomics [15]. We performed this study with a long-term goal to
investigate unique hippocampal gene proﬁling on the hippocampus of
adult mouse affected by four-weeks of ASX supplementation using
whole-genome DNA microarray analysis with the dye-swap methods
(Agilent Technologies). In this study, we show that the ASX-induced
genes have sufﬁcient validity and reliability through a validation pro-
cess including the quality control with housekeeping genes and the
dye-swap based normalization. Therefore, our deposited dataset could
be recognized as a ﬁrst ASX-inﬂuenced transcriptome analysis on the
hippocampus of adult mouse. Furthermore, these large numbers of
gene inventories will also provide a promising basis for understanding
the complexmolecularmechanisms that underlie neurobiological effect
of ASXon the hippocampus, the critical region for learning andmemory,
through highlighting potential candidate genes.
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